Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
  1. DEFA14A Proxy Proxy Materials
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. DEFA14A Proxy Proxy Materials
  5. DEFA14A Proxy Proxy Materials
  6. 8-K Event Material agreement · Regulation FD disclosure
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Insider Changes in Ownership
  12. 8-K Event Material agreement · Other events
  13. 424B5 Offering Prospectus
  14. S-3MEF Other S-3MEF
  15. 424B5 Offering Prospectus
  16. 8-K Event Regulation FD disclosure · Other events
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 8-K/A Event Executive or director change
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 1 of 14 · 277 filings